Sonnet BioTherapeutics I... (SONN)
NASDAQ: SONN
· Real-Time Price · USD
3.53
-0.23 (-6.12%)
At close: Aug 15, 2025, 3:59 PM
3.50
-0.85%
After-hours: Aug 15, 2025, 07:58 PM EDT
Sonnet BioTherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | -3.78M | -3.49M | -3.16M | -3.13M | -3.51M | 365.43K | -1.17M | -3.68M | -3.95M | -5.67M | -5.54M | -7.44M | -7.88M | -8.21M | -6.2M | -6.95M | -6.12M | -6.04M | -5.88M |
Depreciation & Amortization | 22.16K | 22.09K | 22.19K | 21.61K | 21.04K | 20.5K | 19.97K | 19.47K | 18.98K | 18.87K | 18.43K | 17.93K | 23.69K | 26.19K | 25.45K | 24.79K | 24.07K | 23.51K | 22.8K |
Stock-Based Compensation | n/a | n/a | 60.4K | -170.79K | 60.4K | 60.4K | 50.01K | 50.01K | 50.01K | 57K | 91.62K | 85.51K | 107.89K | 350.89K | 332.07K | 317.66K | 317.66K | 370.06K | 370.06K |
Other Working Capital | -1.64M | 940.74K | 696.15K | -384.57K | 210.36K | 364.27K | -2.13M | -197.85K | -974.02K | 895.11K | -207.54K | -662.25K | 351.46K | 133.1K | -699.88K | -959K | -182.77K | 203.58K | 300.46K |
Other Non-Cash Items | 2.66M | 487.32K | 12K | 231.19K | 372.16K | n/a | -24.77K | 368.62K | -198.62K | 12K | 100K | 99.6K | 586.25K | 165.63K | 120K | -22.43M | n/a | 308.00 | 316.00 |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 36.77K | -368.62K | 368.62K | n/a | n/a | n/a | n/a | n/a | n/a | 22.43M | -125.5K | n/a | n/a |
Change in Working Capital | -666.32K | 510.44K | 155.87K | -123.58K | -17.64K | 277.48K | -2.01M | -951.85K | -2.46M | 883.67K | -583.08K | 1.07M | -665.5K | 2.06M | -2.37M | 671.5K | 54.49K | -142.37K | 502.38K |
Operating Cash Flow | -1.76M | -2.47M | -2.91M | -3.17M | -3.07M | 723.79K | -3.09M | -4.56M | -6.17M | -4.7M | -5.92M | -6.16M | -7.82M | -5.61M | -8.09M | -5.94M | -5.84M | -5.79M | -4.98M |
Capital Expenditures | n/a | n/a | n/a | n/a | -12K | n/a | -3 | -170K | -12K | -261.25K | n/a | -24.6K | -586.25K | -165.63K | -120K | -3.62K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -12K | n/a | n/a | -12K | n/a | n/a | n/a | -12K | n/a | n/a | 61.65K | -586.25K | -165.63K | -120K | -3.62K | n/a | n/a | n/a |
Investing Cash Flow | n/a | -12K | n/a | n/a | -12K | n/a | n/a | -170K | -12K | -261.25K | n/a | -24.6K | -586.25K | -165.63K | -120K | -3.62K | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -20.12K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 21.05K | -370.2K | -88.87K | -212.93K | 2.79M | -15K | n/a | n/a | 1.81M | n/a | n/a | 2.17M | n/a | n/a | n/a | n/a | n/a | 10.18M | 2.00 |
Financial Cash Flow | 21.05K | -318.96K | 7.62M | -234.71K | 2.85M | 41K | 3.84M | -17.7K | 1.81M | 14.65M | 4.56M | 4.01M | 33.00 | n/a | n/a | 27.53M | 5.14M | 10.18M | -20.12K |
Net Cash Flow | -1.74M | -2.8M | 4.71M | -3.4M | -231.85K | 764.79K | 747.13K | -4.75M | -4.37M | 9.69M | -1.35M | -2.17M | -8.41M | -5.77M | -8.21M | 21.58M | -700.62K | 4.39M | -5M |
Free Cash Flow | -1.76M | -2.47M | -2.91M | -3.17M | -3.08M | 723.79K | -3.09M | -4.73M | -6.18M | -4.96M | -5.92M | -6.19M | -8.41M | -5.77M | -8.21M | -5.94M | -5.84M | -5.79M | -4.98M |